Ahmad, Z., Tyagi, S., Minkowski, A., Peloquin, C. A., Grosset, J. H., & Nuermberger, E. L. (2013). Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens with or without Continuation of Pyrazinamide in Murine Tuberculosis. American Thoracic Society.
Citação norma ChicagoAhmad, Zahoor, Sandeep Tyagi, Austin Minkowski, Charles A. Peloquin, Jacques H. Grosset, and Eric L. Nuermberger. Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens With or Without Continuation of Pyrazinamide in Murine Tuberculosis. American Thoracic Society, 2013.
Citação norma MLAAhmad, Zahoor, et al. Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens With or Without Continuation of Pyrazinamide in Murine Tuberculosis. American Thoracic Society, 2013.